GHRP-6 (growth hormone-releasing peptide-6) is a synthetic hexapeptide with the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 that acts as a growth hormone secretagogue, stimulating growth hormone (GH) release from the pituitary by activating the ghrelin receptor (GHS-R1a). First characterized in the late 1980s, it was among the earliest synthetic secretagogues studied in animal and human research models, and it remains a reference compound in laboratory work on GH regulation, the ghrelin signaling system, and the scavenger receptor CD36. This article summarizes its background, mechanism, the published literature, and how it is handled in the laboratory. As of 2026, GHRP-6 continues to appear in the peer-reviewed literature, including recent mechanistic studies of tissue protection.
What Is GHRP-6?
GHRP-6 is a six-amino-acid peptide developed from structure-activity work on met-enkephalin derivatives during efforts to find compounds that release growth hormone. It was one of the first peptidyl secretagogues shown to selectively stimulate GH release in vitro and in vivo across several species, and its characterization helped drive the search that ultimately identified ghrelin as the endogenous ligand for the receptor GHRP-6 targets. Because it acts on a different receptor than growth hormone-releasing hormone (GHRH), it is frequently used in research to distinguish the two arms of GH control.
Mechanism of Action
GHRP-6 is an agonist at the growth hormone secretagogue receptor type 1a (GHS-R1a), a G protein-coupled receptor expressed in the anterior pituitary and hypothalamus. Receptor activation engages the phospholipase C pathway, generating inositol (1,4,5)-trisphosphate and diacylglycerol and producing a rise in intracellular calcium in pituitary somatotrophs, which drives GH release. In cultured rat anterior pituitary cells, GHRP-6 was shown to activate this inositol-trisphosphate/diacylglycerol pathway directly. Studies in human research subjects have also shown that a substantial part of the GH response to GHRP-6 depends on endogenous GHRH, indicating the two systems act cooperatively rather than in isolation.
Beyond the pituitary, GHRP-6 binds a second receptor: the scavenger receptor CD36, which is expressed in cardiomyocytes, microvascular endothelium, and macrophages. This dual binding underlies much of the research interest in GHRP-6 outside GH biology, and it is why newer chemistry programs have designed azapeptide analogues that separate CD36 binding from GHS-R1a binding.
Published Research Overview
GHRP-6 has been examined across a range of experimental systems:
- An early human study reported that a synthetic hexapeptide selectively stimulated GH release in healthy research subjects in a dose-dependent manner, establishing GHRP-6 as a selective secretagogue (Bowers and colleagues).
- A study in normal human subjects found that GHRP-6 administration was associated with changes in sleep as well as release of GH, ACTH, and cortisol, illustrating that its effects are not limited strictly to GH.
- Work published in Circulation Research identified CD36 as the receptor mediating the cardiovascular actions of growth hormone-releasing peptides in the heart, a finding that reframed GHRP-6 as a probe for CD36 biology.
- A 2014 review in the International Journal of Molecular Sciences detailed the intracellular signaling and regulation of the growth hormone secretagogue receptor, providing mechanistic context for how GHRP-6 and related ligands act.
- A 2024 study reported that GHRP-6 attenuated doxorubicin-induced myocardial and extra-myocardial damage in an animal model by activating pro-survival pathways, offering a current data point on its cytoprotective mechanisms in experimental settings.
- Research in wound-healing models found that GHRP-6 influenced granulation tissue and fibrogenic cytokine expression, effects attributed to CD36 and GHS-R1a engagement.
How Does GHRP-6 Differ From Other Secretagogues?
GHRP-6 differs from GHRH analogues such as sermorelin, tesamorelin, and CJC-1295 because it acts through GHS-R1a rather than the GHRH receptor. Compared with ipamorelin, a later and more selective GHS-R1a agonist, GHRP-6 is less selective: it is a potent stimulator of appetite in animal models and, in some studies, is associated with release of ACTH, cortisol, and prolactin alongside GH. Its additional binding to CD36 further separates it from the cleaner GH-focused profile of newer secretagogues, which is precisely why it remains useful as a research tool for studying both pathways.
Storage & Handling
Dynamite Research Peptides supplies GHRP-6 in lyophilized (freeze-dried) form. Store the powder at -20°C or below, protected from light and moisture. Reconstitute immediately before use with a sterile solvent as indicated on the Certificate of Analysis (COA), and avoid repeated freeze-thaw cycles, which can degrade peptide integrity. Handle with appropriate personal protective equipment in a well-ventilated laboratory area.
Conclusion
GHRP-6 is a well-characterized research secretagogue valuable for studying GH regulation, ghrelin-receptor signaling, and CD36-mediated pathways. Its dual receptor activity makes it a versatile probe in laboratory investigations of endocrine and cytoprotective mechanisms. Our GHRP-6 is high-purity, third-party tested, and ships with a COA so experimental results stay reliable and reproducible.
Frequently Asked Questions
What receptor does GHRP-6 act on?
GHRP-6 is an agonist at the growth hormone secretagogue receptor GHS-R1a, the same receptor targeted by the endogenous hormone ghrelin. It also binds the scavenger receptor CD36, which mediates several of its non-pituitary effects observed in research models.
Is GHRP-6 the same as ghrelin?
No. GHRP-6 is a synthetic hexapeptide that predates the discovery of ghrelin. Its characterization as a secretagogue helped researchers identify ghrelin as the natural ligand for the GHS-R1a receptor, but the two are distinct molecules.
What is the purity level of Dynamite Research Peptides' GHRP-6?
Our GHRP-6 is typically 99%+ pure, verified by HPLC analysis. Detailed purity data is provided on the Certificate of Analysis (COA) included with each product.
What research applications is GHRP-6 used for?
It is used in laboratory studies of growth hormone regulation, ghrelin-receptor and CD36 signaling, metabolic pathways, and cytoprotective mechanisms in cell and animal models.
All products are for research use only — not for human or animal consumption.